Records containing: Osteosarcoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-08-04Evaluation of Dietary Habits, Metabolome, Immune Profile and Microbiota in Patients With Bone Sarcoma
-
CLINICAL_TRIALS study record update · 2023-08-04Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse
-
CLINICAL_TRIALS study record update · 2023-07-07A Phase II Study of M6620 (VX-970) in Selected Solid Tumors
-
CLINICAL_TRIALS study record update · 2023-06-22Phase I/II Study of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma, and Other GD2(+) Solid Tumors
-
CLINICAL_TRIALS study record update · 2023-05-09A Clinical Safety and Efficacy Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-04-18A Dose-Finding Study of N-Acetylcysteine (NAC) to Prevent Cisplatin-induced Hearing Loss in Children With Cancer
-
CLINICAL_TRIALS study record update · 2023-04-06Extracorporeal Shock Wave Therapy on Osteoblast-Like Cells In- Vitro Study
-
CLINICAL_TRIALS study record update · 2023-02-14Drug Sensitivity Testing and Mutation Profiling in Childhood Sarcomas
-
CLINICAL_TRIALS study record update · 2022-11-28Phase 2 Trial of XL184 (Cabozantinib) an Oral Small-Molecule Inhibitor of Multiple Kinases, in Children and Young Adults With Refractory Sarcomas, Wilms Tumor, and Other Rare Tumors
-
CLINICAL_TRIALS study record update · 2022-11-15Construction and Clinical Application of Microfluidic Exosome Chip for Early Diagnosis of Pulmonary Metastasis of Osteosarcoma
-
CLINICAL_TRIALS study record update · 2022-10-21A Study of Etoposide and Ifosfamide Combined With or Without Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma
-
CLINICAL_TRIALS study record update · 2022-10-14A Dose Finding Study of CycloSam® (153Sm-DOTMP) Combined With External Beam Radiotherapy to Treat High Risk Osteosarcoma and Other Solid Tumors Metastatic to Bone
-
CLINICAL_TRIALS study record update · 2022-10-04Phase Ib Study to Evaluate the Efficacy, Safety and Tolerability of IBI188 Combination Therapy in Subjects With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2022-09-13Treatment of Relapsed or Refractory Neuroblastoma and Osteosarcoma With Ex-Vivo Expanded and Activated Haploidentical NK Cells and Hu14.18-IL2
-
CLINICAL_TRIALS study record update · 2022-08-25Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas (COSS-Registry)
-
CLINICAL_TRIALS study record update · 2022-06-03A Study to Assess the Therapeutic Efficacy in Advanced Osteosarcoma Patients In the Clinical Trial of SHR1020-SHR-1210-II-OS (Famitinib and Camrelizumab on Chemo-refractory Osteosarcoma) Based on Genomic Analyses of Tumor Specimens
-
CLINICAL_TRIALS study record update · 2022-04-05The Prognostic Value of Serum Biomarkers in Osteosarcoma
-
CLINICAL_TRIALS study record update · 2022-03-31Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
-
CLINICAL_TRIALS study record update · 2022-02-08A Phase 1, Open-label, Dose Escalation Study of MGA271 in Pediatric Patients With B7-H3-Expressing Relapsed or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2022-01-31Predictive Models of Treatment Responses and Survival Outcomes in Patients With Osteosarcoma
-
CLINICAL_TRIALS study record update · 2021-12-07A Phase 2 Study of 9-ING-41, a Glycogen Synthase Kinase-3 Beta (GSK-3β) Inhibitor, Combined With Chemotherapy in Advanced Soft Tissue and Bone Sarcomas
-
CLINICAL_TRIALS study record update · 2021-11-09Efficacy of Epidural Analgesia Initiated in the Preoperative Period in Lower Extremity Osteosarcoma
-
CLINICAL_TRIALS study record update · 2021-10-28Assessing the Safety, Feasibility, Cost Effectiveness and Patient Satisfaction of Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma
-
CLINICAL_TRIALS study record update · 2021-09-16A Phase II Trial of Avelumab, A Fully Human Antibody That Targets Cells Expressing PD-L1, in Patients With Recurrent or Progressive Osteosarcoma
-
CLINICAL_TRIALS study record update · 2021-08-06Efficacy of Selected Exercise Program on Distal End Femoral Sarcoma Patients Undergoing Knee Modular Endoprosthesis: RCT